Advanced Enzyme Technologies announced its financial results for the second quarter and half-year ended September 30, 2026 (FY27). The company reported a 16% year-on-year growth in its top line, reaching INR2,145 million for the quarter. EBITDA saw a substantial 20% year-on-year increase to INR721 crore. Profit After Tax (PAT) also grew by 14% year-on-year to INR512 million.
Advanced Enzyme Technologies Reports Strong Q2 FY27 Performance
Advanced Enzyme Technologies Limited has announced robust financial results for the second quarter and the first half of the financial year 2027 (FY27), ending September 30, 2026. The company highlighted a 16% year-on-year increase in its consolidated revenue for the quarter, reaching INR2,145 million. Sequentially, revenue grew by 12%. For the first half of FY27, revenue grew by 10% over the corresponding period last year.
Profitability and Margins Increase
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) for the quarter increased by 20% year-on-year to INR721 crore, up from INR601 crore in Q2 FY26. Sequentially, EBITDA saw a significant jump of 36%. The EBITDA margin stood at 34% for the quarter, compared to 33% in Q2 FY26. Profit After Tax (PAT) for the quarter grew by 14% year-on-year to INR512 million, with a PAT margin of 24%.
Segmental Performance Highlights
The company detailed strong performance across its business segments. Human Healthcare revenues grew by 6% year-on-year to INR1,285 million. Animal Healthcare saw an impressive 37% year-on-year growth, contributing approximately 12% to overall revenues. Bio-Processing delivered a strong 43% year-on-year growth in revenue, accounting for about 17% of total revenues. Specialized Manufacturing reported a healthy 25% year-on-year growth.
Strategic Initiatives and Outlook
The management expressed confidence in sustained growth, attributing it to a strategic focus on innovation, operational excellence, and customer-centric initiatives. The company also announced the successful completion of its buyback, acquiring 2.41 million equity shares at an average price of INR289.09 per share. This move reflects the commitment to enhancing shareholder value. The company anticipates continued growth momentum and remains watchful of the challenging global economic environment.
Source: BSE
